{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T18:22:03Z","timestamp":1740162123641,"version":"3.37.3"},"reference-count":14,"publisher":"Georg Thieme Verlag KG","issue":"01","license":[{"start":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T00:00:00Z","timestamp":1699660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AJP Rep"],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Drug-induced liver injury (DILI) is a common cause of transaminitis in pregnancy. A 34-year-old G3P2012 presented 3 weeks postpartum for preeclampsia with severe features. After receiving acute antihypertensive medications, she was discharged home with labetalol. She presented 5 months later with general malaise, scleral icterus, nausea, and mild right upper quadrant pain and found to have significantly elevated transaminitis. She had a negative infectious, autoimmune, biliary, and steatohepatitis workup. A liver biopsy was performed supporting the diagnosis of DILI. After patient self-discontinued labetalol, her hepatitis significantly improved. However, she developed chronic DILI and liver enzymes normalized during her subsequent pregnancy at 34 weeks. Patient's written consent was obtained for this case report. Chronic DILI secondary to labetalol use is a rare and potentially fatal condition that should be considered on the differential for transaminitis during pregnancy and postpartum period.<\/jats:p>","DOI":"10.1055\/a-2209-4636","type":"journal-article","created":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T23:36:21Z","timestamp":1699745781000},"page":"e43-e47","source":"Crossref","is-referenced-by-count":0,"title":["Chronic Drug-Induced Liver Injury from Labetalol during the Postpartum Period: A Case Report"],"prefix":"10.1055","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8096-2888","authenticated-orcid":false,"given":"Bruce","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Rochester General Hospital, Rochester, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suriya","family":"Xiong","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Care \u2013 Ambulatory Care, Digestive Health Center, University of Iowa Hospitals & Clinics, Coralville, Iowa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth A.","family":"Westen","sequence":"additional","affiliation":[{"name":"Department of Maternal-Fetal Medicine, Rochester General Hospital, Rochester, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie Ann","family":"Warner","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Rochester General Hospital, Rochester, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2024,1,23]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"4080","DOI":"10.12659\/MSM.907723","article-title":"Liver disease during pregnancy: a challenging clinical issue","volume":"24","author":"I Mikolasevic","year":"2018","journal-title":"Med Sci Monit"},{"issue":"05","key":"ref2","doi-asserted-by":"crossref","first-page":"878","DOI":"10.14309\/ajg.0000000000001259","article-title":"ACG clinical guideline: diagnosis and management of idiosyncratic drug-induced liver injury","volume":"116","author":"N P Chalasani","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.bpobgyn.2020.03.005","article-title":"Drug-induced liver injury in pregnancy","volume":"68","author":"T T Lao","year":"2020","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"10","key":"ref4","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1007\/s00204-020-02885-1","article-title":"Drug induced liver injury: an update","volume":"94","author":"M Garcia-Cortes","year":"2020","journal-title":"Arch Toxicol"},{"issue":"06","key":"ref5","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1097\/AOG.0000000000003891","article-title":"Gestational hypertension and preeclampsia: ACOG Practice Bulletin, Number 222","volume":"135","year":"2020","journal-title":"Obstet Gynecol"},{"volume-title":"Adverse Drug Reaction Probability Scale (Naranjo) in Drug Induced Liver Injury","year":"2012","key":"ref6"},{"volume-title":"Labetalol","year":"2012","key":"ref7"},{"volume-title":"Roussel Uclaf Causality Assessment Method (RUCAM) in Drug Induced Liver Injury","year":"2012","key":"ref8"},{"issue":"04","key":"ref9","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1177\/1753495X15598909","article-title":"Drug-induced fulminant hepatic failure in pregnancy","volume":"8","author":"T Firoz","year":"2015","journal-title":"Obstet Med"},{"issue":"03","key":"ref10","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1177\/0897190007306173","article-title":"Probable labetalol-induced hepatotoxicity","volume":"20","author":"R Ginzburg","year":"2016","journal-title":"J Pharm Pract"},{"issue":"03","key":"ref11","doi-asserted-by":"crossref","first-page":"e210","DOI":"10.1055\/s-0040-1713789","article-title":"Labetalol-induced hepatotoxicity during pregnancy: a case report","volume":"10","author":"A Whelan","year":"2020","journal-title":"AJP Rep"},{"issue":"01","key":"ref12","doi-asserted-by":"crossref","first-page":"S1102","DOI":"10.14309\/01.ajg.0000784032.10708.6a","article-title":"S2625 DILI leading to acute liver failure in a pregnant patient","volume":"116","author":"K Zucker","year":"2021","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"ref13","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1111\/liv.14195","article-title":"Early ALT response to corticosteroid treatment distinguishes idiosyncratic drug-induced liver injury from autoimmune hepatitis","volume":"39","author":"S Weber","year":"2019","journal-title":"Liver Int"},{"issue":"02","key":"ref14","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.26709","article-title":"Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations","volume":"59","author":"D E Kleiner","year":"2014","journal-title":"Hepatology"}],"container-title":["American Journal of Perinatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2209-4636.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T11:05:49Z","timestamp":1730804749000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2209-4636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,11]]},"references-count":14,"journal-issue":{"issue":"01","published-online":{"date-parts":[[2024,1,23]]},"published-print":{"date-parts":[[2024,1]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2209-4636","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["2157-6998","2157-7005"],"issn-type":[{"type":"print","value":"2157-6998"},{"type":"electronic","value":"2157-7005"}],"subject":[],"published-other":{"date-parts":[[2023,11,11]]},"published":{"date-parts":[[2023,11,11]]}}}